NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 358 filers reported holding NOVOCURE LTD in Q4 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $155,637,437 | -61.2% | 9,636,993 | -0.3% | 0.00% | -60.0% |
Q2 2023 | $401,063,718 | -31.4% | 9,664,186 | -0.6% | 0.01% | -33.3% |
Q1 2023 | $584,438,895 | -16.5% | 9,717,973 | +1.8% | 0.02% | -21.1% |
Q4 2022 | $700,297,096 | +11.9% | 9,547,336 | +15.9% | 0.02% | +5.6% |
Q3 2022 | $625,986,000 | +11.1% | 8,238,835 | +1.6% | 0.02% | +12.5% |
Q2 2022 | $563,627,000 | -14.9% | 8,109,739 | +1.4% | 0.02% | 0.0% |
Q1 2022 | $662,609,000 | +11.8% | 7,997,688 | +1.3% | 0.02% | +23.1% |
Q4 2021 | $592,629,000 | -35.1% | 7,893,313 | +0.4% | 0.01% | -43.5% |
Q3 2021 | $913,312,000 | -47.3% | 7,861,860 | +0.7% | 0.02% | -46.5% |
Q2 2021 | $1,732,220,000 | +56.1% | 7,809,123 | -7.0% | 0.04% | +43.3% |
Q1 2021 | $1,109,886,000 | -22.2% | 8,396,783 | +1.9% | 0.03% | -26.8% |
Q4 2020 | $1,426,536,000 | +56.2% | 8,243,970 | +0.4% | 0.04% | +36.7% |
Q3 2020 | $913,551,000 | +106.1% | 8,207,262 | +9.8% | 0.03% | +87.5% |
Q2 2020 | $443,244,000 | -11.3% | 7,474,620 | +0.8% | 0.02% | -23.8% |
Q1 2020 | $499,545,000 | -18.3% | 7,418,256 | +2.3% | 0.02% | 0.0% |
Q4 2019 | $611,242,000 | +17.8% | 7,253,370 | +4.5% | 0.02% | +10.5% |
Q3 2019 | $518,997,000 | +33.2% | 6,940,317 | +12.6% | 0.02% | +26.7% |
Q2 2019 | $389,565,000 | +28.0% | 6,161,088 | -2.5% | 0.02% | +25.0% |
Q1 2019 | $304,240,000 | +41.6% | 6,315,973 | -1.6% | 0.01% | +20.0% |
Q4 2018 | $214,908,000 | -24.4% | 6,418,965 | +18.3% | 0.01% | -9.1% |
Q3 2018 | $284,265,000 | +83.5% | 5,424,908 | +9.6% | 0.01% | +83.3% |
Q2 2018 | $154,881,000 | +47.1% | 4,948,273 | +2.4% | 0.01% | +20.0% |
Q1 2018 | $105,298,000 | +13.2% | 4,830,158 | +4.9% | 0.01% | +25.0% |
Q4 2017 | $93,042,000 | +4.7% | 4,606,070 | +2.8% | 0.00% | 0.0% |
Q3 2017 | $88,897,000 | +20.0% | 4,478,442 | +4.5% | 0.00% | 0.0% |
Q2 2017 | $74,111,000 | +200.2% | 4,283,862 | +40.5% | 0.00% | +300.0% |
Q1 2017 | $24,688,000 | +15.5% | 3,047,940 | +12.0% | 0.00% | 0.0% |
Q4 2016 | $21,371,000 | -4.2% | 2,722,428 | +4.2% | 0.00% | 0.0% |
Q3 2016 | $22,303,000 | -18.9% | 2,611,707 | +10.8% | 0.00% | -50.0% |
Q2 2016 | $27,511,000 | +8746.0% | 2,357,427 | +10863.8% | 0.00% | – |
Q1 2016 | $311,000 | -37.9% | 21,502 | -3.9% | 0.00% | – |
Q4 2015 | $501,000 | – | 22,381 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |